HEADER LIGASE/LIGASE INHIBITOR 09-APR-16 5J9F TITLE HUMAN GAR TRANSFORMYLASE IN COMPLEX WITH GAR AND (4-{[2-(2-AMINO-4- TITLE 2 OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-6-YL)ETHYL]AMINO}BENZOYL)- TITLE 3 L-GLUTAMIC ACID (AGF183) COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRIFUNCTIONAL PURINE BIOSYNTHETIC PROTEIN ADENOSINE-3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 808-1010; COMPND 5 EC: 6.3.4.13,6.3.3.1,2.1.2.2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GART, PGFT, PRGS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET22B KEYWDS GAR TRANSFORMYLASE, ANTIFOLATE, LIGASE-LIGASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.WONG,S.M.DEIS,C.E.DANN III REVDAT 5 27-SEP-23 5J9F 1 REMARK REVDAT 4 04-DEC-19 5J9F 1 REMARK REVDAT 3 20-SEP-17 5J9F 1 JRNL REMARK REVDAT 2 21-SEP-16 5J9F 1 JRNL REVDAT 1 10-AUG-16 5J9F 0 JRNL AUTH L.K.GOLANI,A.WALLACE-POVIRK,S.M.DEIS,J.WONG,J.KE,X.GU, JRNL AUTH 2 S.RAGHAVAN,M.R.WILSON,X.LI,L.POLIN,P.W.DE WAAL,K.WHITE, JRNL AUTH 3 J.KUSHNER,C.O'CONNOR,Z.HOU,H.E.XU,K.MELCHER,C.E.DANN, JRNL AUTH 4 L.H.MATHERLY,A.GANGJEE JRNL TITL TUMOR TARGETING WITH NOVEL 6-SUBSTITUTED PYRROLO [2,3-D] JRNL TITL 2 PYRIMIDINE ANTIFOLATES WITH HETEROATOM BRIDGE SUBSTITUTIONS JRNL TITL 3 VIA CELLULAR UPTAKE BY FOLATE RECEPTOR ALPHA AND THE JRNL TITL 4 PROTON-COUPLED FOLATE TRANSPORTER AND INHIBITION OF DE NOVO JRNL TITL 5 PURINE NUCLEOTIDE BIOSYNTHESIS. JRNL REF J.MED.CHEM. V. 59 7856 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27458733 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00594 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.02 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 19940 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.150 REMARK 3 FREE R VALUE TEST SET COUNT : 1825 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.0242 - 4.9350 0.99 1500 151 0.1426 0.1771 REMARK 3 2 4.9350 - 3.9182 1.00 1419 142 0.1285 0.1576 REMARK 3 3 3.9182 - 3.4232 1.00 1396 142 0.1673 0.1943 REMARK 3 4 3.4232 - 3.1103 1.00 1395 148 0.2009 0.2326 REMARK 3 5 3.1103 - 2.8875 1.00 1400 142 0.2063 0.2701 REMARK 3 6 2.8875 - 2.7173 1.00 1384 141 0.2081 0.2568 REMARK 3 7 2.7173 - 2.5812 1.00 1384 135 0.1945 0.2652 REMARK 3 8 2.5812 - 2.4689 1.00 1381 135 0.1816 0.2184 REMARK 3 9 2.4689 - 2.3738 1.00 1371 138 0.1846 0.2149 REMARK 3 10 2.3738 - 2.2919 1.00 1377 138 0.1761 0.2258 REMARK 3 11 2.2919 - 2.2203 1.00 1373 135 0.1910 0.2233 REMARK 3 12 2.2203 - 2.1568 1.00 1374 139 0.1966 0.2637 REMARK 3 13 2.1568 - 2.1000 1.00 1361 139 0.2259 0.2723 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 1574 REMARK 3 ANGLE : 1.476 2139 REMARK 3 CHIRALITY : 0.072 256 REMARK 3 PLANARITY : 0.006 271 REMARK 3 DIHEDRAL : 13.722 564 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 31.7160 -19.1007 -22.6729 REMARK 3 T TENSOR REMARK 3 T11: 0.1730 T22: 0.1388 REMARK 3 T33: 0.1817 T12: -0.0108 REMARK 3 T13: 0.0318 T23: 0.0117 REMARK 3 L TENSOR REMARK 3 L11: 1.0309 L22: 0.8954 REMARK 3 L33: 1.4334 L12: 0.1305 REMARK 3 L13: -0.6686 L23: -0.2300 REMARK 3 S TENSOR REMARK 3 S11: 0.1441 S12: 0.0173 S13: 0.2381 REMARK 3 S21: 0.0145 S22: -0.0167 S23: -0.0368 REMARK 3 S31: -0.1956 S32: 0.0272 S33: 0.0058 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5J9F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000220055. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-E REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22067 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 40.017 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.75000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4ZZ1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS (PH 7.5), 0.333 MM NACL, REMARK 280 18% POLYETHYLENE GLYCOL (PEG) 3350, AND 2% PEG 400, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.52867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 33.76433 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 33.76433 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 67.52867 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9340 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 807 REMARK 465 LYS A 1008 REMARK 465 GLU A 1009 REMARK 465 GLU A 1010 REMARK 465 HIS A 1011 REMARK 465 HIS A 1012 REMARK 465 HIS A 1013 REMARK 465 HIS A 1014 REMARK 465 HIS A 1015 REMARK 465 HIS A 1016 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A1000 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 939 -151.36 -122.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GAR A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 83A A 1102 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5IZQ RELATED DB: PDB DBREF 5J9F A 808 1010 UNP P22102 PUR2_HUMAN 808 1010 SEQADV 5J9F MET A 807 UNP P22102 INITIATING METHIONINE SEQADV 5J9F ALA A 905 UNP P22102 GLN 905 ENGINEERED MUTATION SEQADV 5J9F HIS A 1011 UNP P22102 EXPRESSION TAG SEQADV 5J9F HIS A 1012 UNP P22102 EXPRESSION TAG SEQADV 5J9F HIS A 1013 UNP P22102 EXPRESSION TAG SEQADV 5J9F HIS A 1014 UNP P22102 EXPRESSION TAG SEQADV 5J9F HIS A 1015 UNP P22102 EXPRESSION TAG SEQADV 5J9F HIS A 1016 UNP P22102 EXPRESSION TAG SEQRES 1 A 210 MET ALA ARG VAL ALA VAL LEU ILE SER GLY THR GLY SER SEQRES 2 A 210 ASN LEU GLN ALA LEU ILE ASP SER THR ARG GLU PRO ASN SEQRES 3 A 210 SER SER ALA GLN ILE ASP ILE VAL ILE SER ASN LYS ALA SEQRES 4 A 210 ALA VAL ALA GLY LEU ASP LYS ALA GLU ARG ALA GLY ILE SEQRES 5 A 210 PRO THR ARG VAL ILE ASN HIS LYS LEU TYR LYS ASN ARG SEQRES 6 A 210 VAL GLU PHE ASP SER ALA ILE ASP LEU VAL LEU GLU GLU SEQRES 7 A 210 PHE SER ILE ASP ILE VAL CYS LEU ALA GLY PHE MET ARG SEQRES 8 A 210 ILE LEU SER GLY PRO PHE VAL ALA LYS TRP ASN GLY LYS SEQRES 9 A 210 MET LEU ASN ILE HIS PRO SER LEU LEU PRO SER PHE LYS SEQRES 10 A 210 GLY SER ASN ALA HIS GLU GLN ALA LEU GLU THR GLY VAL SEQRES 11 A 210 THR VAL THR GLY CYS THR VAL HIS PHE VAL ALA GLU ASP SEQRES 12 A 210 VAL ASP ALA GLY GLN ILE ILE LEU GLN GLU ALA VAL PRO SEQRES 13 A 210 VAL LYS ARG GLY ASP THR VAL ALA THR LEU SER GLU ARG SEQRES 14 A 210 VAL LYS LEU ALA GLU HIS LYS ILE PHE PRO ALA ALA LEU SEQRES 15 A 210 GLN LEU VAL ALA SER GLY THR VAL GLN LEU GLY GLU ASN SEQRES 16 A 210 GLY LYS ILE CYS TRP VAL LYS GLU GLU HIS HIS HIS HIS SEQRES 17 A 210 HIS HIS HET GAR A1101 18 HET 83A A1102 32 HETNAM GAR GLYCINAMIDE RIBONUCLEOTIDE HETNAM 83A N-(4-{[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3- HETNAM 2 83A D]PYRIMIDIN-6-YL)ETHYL]AMINO}BENZENE-1-CARBONYL)-L- HETNAM 3 83A GLUTAMIC ACID HETSYN 83A ANTIFOLATE AGF183 FORMUL 2 GAR C7 H13 N2 O8 P 2- FORMUL 3 83A C20 H22 N6 O6 FORMUL 4 HOH *52(H2 O) HELIX 1 AA1 GLY A 818 ARG A 829 1 12 HELIX 2 AA2 VAL A 847 ALA A 856 1 10 HELIX 3 AA3 ASN A 864 TYR A 868 5 5 HELIX 4 AA4 ASN A 870 PHE A 885 1 16 HELIX 5 AA5 SER A 900 TRP A 907 1 8 HELIX 6 AA6 ASN A 926 GLY A 935 1 10 HELIX 7 AA7 THR A 968 SER A 993 1 26 SHEET 1 AA1 7 THR A 860 VAL A 862 0 SHEET 2 AA1 7 GLN A 836 SER A 842 1 N SER A 842 O ARG A 861 SHEET 3 AA1 7 ARG A 809 ILE A 814 1 N VAL A 810 O GLN A 836 SHEET 4 AA1 7 ILE A 889 LEU A 892 1 O CYS A 891 N LEU A 813 SHEET 5 AA1 7 MET A 911 HIS A 915 1 O LEU A 912 N LEU A 892 SHEET 6 AA1 7 VAL A 938 PHE A 945 -1 O THR A 942 N HIS A 915 SHEET 7 AA1 7 ILE A 955 PRO A 962 -1 O VAL A 961 N THR A 939 SHEET 1 AA2 2 VAL A 996 LEU A 998 0 SHEET 2 AA2 2 ILE A1004 TRP A1006 -1 O CYS A1005 N GLN A 997 CISPEP 1 LEU A 919 PRO A 920 0 12.51 SITE 1 AC1 15 THR A 817 GLY A 818 SER A 819 ASN A 820 SITE 2 AC1 15 GLY A 894 PRO A 916 LYS A 977 GLU A 980 SITE 3 AC1 15 83A A1102 HOH A1201 HOH A1207 HOH A1208 SITE 4 AC1 15 HOH A1209 HOH A1211 HOH A1234 SITE 1 AC2 16 PHE A 895 MET A 896 ARG A 897 ILE A 898 SITE 2 AC2 16 LEU A 899 VAL A 904 ASN A 913 HIS A 944 SITE 3 AC2 16 VAL A 946 ALA A 947 GLU A 948 VAL A 950 SITE 4 AC2 16 ASP A 951 GAR A1101 HOH A1201 HOH A1205 CRYST1 75.386 75.386 101.293 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013265 0.007659 0.000000 0.00000 SCALE2 0.000000 0.015317 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009872 0.00000